Association between body mass index and liver disorders: An epidemiological study

Journal of Hepatology

Volumn 37, Issue 6, 2002, Pages 741-747

  Meier, Christoph R ^a,b   Krähenbühl, Stephan ^a,c   Schlienger, Raymond G ^a,c   Jick, Hershel ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Body mass index; Epidemiology; Liver disorders; Obesity

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; CASE CONTROL STUDY; MIDDLE AGED; RISK;

ADULT; AGED; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER DISEASES; MALE; MIDDLE AGED; OBESITY; ODDS RATIO;

EID: 0036892976     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00298-2     Document Type: Article

References (31)

1. Galambos JT, Wills CE. Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 1978:74:1191-1195.
2. Watanabe A, Kobayashi M, Yoshitomi S, Nagashima H. Liver fibrosis in obese patients with fatty livers. J Med 1989;20:357-362.
3. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990;12:1106-1110.
4. Bizzaro N, Tremolada F, Casarin C, Bonetti P, Noventa F, Diodati G, et al. Serum alanine aminotransferase levels among volunteer blood donors: Effect of sex, alcohol intake and obesity. Ital J Gastroenterol 1992;24:237-241.
5. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
6. Tominaga K, Kurata JH, Chen YK, Fujimoto S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-2009.
7. Burns CJ, Boswell JM, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med 1996;38:1248-1252.
8. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997;25:108-111.
9. Lozano M, Cid J, Bedini JL, Mazzara L, Gimenez N, Mas E, et al. Study of serum alanine-aminotransferase levels in blood donors in Spain. Haematologica 1998;83:237-239.
10. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, et al. Factors associated with serum alanine aminotransferase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998;27:1213-1219.
11. Leclerq I, Horsmans Y, De Bruyere M, Geubel AP. Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors. Acta Gastroenterol Belg 1999;62:16-20.
12. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-1517.
13. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: Correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000;24:772-776.
14. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, et al. Liver fibrosis in overweight patients. Gastroenterology 2000;118:1117-1123.
15. Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc 2000;75:733-739.
16. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-145.
17. James OFW, Day CP. Non-alcoholic-steatohepatitis (NASH): A disease of emerging identity and importance. J Hepatol 1998;29:495-501.
18. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998;115:997-1001.
19. Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349-1355.
20. Bray GA. Health hazards of obesity. Endocrinol Metab Clin North Am 1996;25:907-919.
21. Luyckx FH, Desaive C, Thiry A, Dewe J, Scheen AJ, Gielen JE, et al. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998;22:222-226.
22. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001;161:1581-1586.
23. WHO. Obesity Epidemic Puts Millions at Risk from Related Diseases, WHO Press Release 46, June 12, 1997.
24. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991;302:766-768.
25. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992;1:347-349.
26. Walley T, Mantgani A. The UK general practice research database. Lancet 1997;350:1097-1099.
27. Jick H. A database worth saving. Lancet 1997;350:1045.
28. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-425.
29. Jick S, Stender M, Myers MW. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents. Diabetes Care 1999;22:2067-2071.
30. Bénichou C. Report of an International Consensus Meeting. Criteria of drug-induced liver disorder. J Hepatol 1990;11:272-276.
31. Erbey JR, Silberman C, Lydick E. Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 2000;109:588-590.